PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
15667832-8	2005	Additional analyses indicate that the tumor suppressor p53 and p53-regulated proapoptotic Bax were upregulated in vivo and in vitro following CPA treatment in combination with DOX, suggesting that upregulation of p53 may contribute to the enhancement of antitumor effect of CPA by DOX.	Cyclophosphamide	142-145	transformation related protein 53, pseudogene	Mus musculus	55-58	
15667832-8	2005	Additional analyses indicate that the tumor suppressor p53 and p53-regulated proapoptotic Bax were upregulated in vivo and in vitro following CPA treatment in combination with DOX, suggesting that upregulation of p53 may contribute to the enhancement of antitumor effect of CPA by DOX.	Cyclophosphamide	142-145	transformation related protein 53, pseudogene	Mus musculus	63-66	
15667832-8	2005	Additional analyses indicate that the tumor suppressor p53 and p53-regulated proapoptotic Bax were upregulated in vivo and in vitro following CPA treatment in combination with DOX, suggesting that upregulation of p53 may contribute to the enhancement of antitumor effect of CPA by DOX.	Cyclophosphamide	142-145	transformation related protein 53, pseudogene	Mus musculus	63-66	
15667832-8	2005	Additional analyses indicate that the tumor suppressor p53 and p53-regulated proapoptotic Bax were upregulated in vivo and in vitro following CPA treatment in combination with DOX, suggesting that upregulation of p53 may contribute to the enhancement of antitumor effect of CPA by DOX.	Cyclophosphamide	274-277	transformation related protein 53, pseudogene	Mus musculus	55-58	
15667832-8	2005	Additional analyses indicate that the tumor suppressor p53 and p53-regulated proapoptotic Bax were upregulated in vivo and in vitro following CPA treatment in combination with DOX, suggesting that upregulation of p53 may contribute to the enhancement of antitumor effect of CPA by DOX.	Cyclophosphamide	274-277	transformation related protein 53, pseudogene	Mus musculus	63-66	
15667832-8	2005	Additional analyses indicate that the tumor suppressor p53 and p53-regulated proapoptotic Bax were upregulated in vivo and in vitro following CPA treatment in combination with DOX, suggesting that upregulation of p53 may contribute to the enhancement of antitumor effect of CPA by DOX.	Cyclophosphamide	274-277	transformation related protein 53, pseudogene	Mus musculus	63-66